Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students

Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students

Ever wondered how prevalent ADHD medication misuse is among college students? This episode of 'This Week in Addiction Medicine' dives into an eye-opening study that examines the link between ADHD medication treatment and the misuse of prescription stimulants on university campuses. Using data from the American College Health Association, the study highlights a concerning association between higher rates of ADHD medication treatment and increased risks of stimulant misuse among students.

It's a must-listen for anyone interested in the dynamics of prescription drug use in educational settings. But that's not all! The episode also explores groundbreaking research on the potential of GLP-1 agonists like semaglutide in treating alcohol use disorder. Early findings suggest these medications could significantly reduce alcohol-related hospitalisations. Intriguing, right? Next up, there's a fascinating study on the connection between prenatal sex steroid exposure and alcohol consumption patterns.

By examining digit ratios, researchers found links that might help predict future alcohol use based on prenatal hormone levels. It's like something out of a sci-fi movie! The episode doesn't shy away from hard-hitting topics either. It covers young adults' impaired driving behaviours when mixing alcohol and cannabis, and discusses the effectiveness of different methods for transferring patients from methadone to buprenorphine.

Plus, there's a look at how alcohol increases aggression by raising pain thresholds – an unexpected twist that adds a whole new layer to understanding intoxicated behaviour. Lastly, you'll hear about the promising results of a wearable alcohol biosensor and its potential applications in health monitoring and relapse detection. The episode wraps up with a study on VK440, a dopamine receptor partial agonist, which shows potential in reducing the reinforcing effects of stimulants like D-amphetamine.

With such a diverse range of topics, this episode offers valuable insights for anyone interested in addiction medicine. Don't miss out on these fascinating discussions!